Latest Pancreatic Cancer Papers and News


We saw some disappointing results from Infinity Pharmaceutical’s latest Phase II trial of IPI-926 and the resulting cancellation of the program.

A recent study also showed that women who had been taking metformin for diabetes had a reduced incidence of pancreatic cancer.

Researchers at the University of Michigan demonstrated that by inhibiting KRAS (the gene associated with the start of pancreatic cancer), pancreatic tumor growth could be stopped and reversed.



About Mark Fortner

I write software for scientists doing drug discovery and cancer research. I'm interested in Design Thinking, Agile Software Development, Web Components, Java, Javascript, Groovy, Grails, MongoDB, Firebase, microservices, the Semantic Web Drug Discovery and Cancer Biology.
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s